←Back to Expert Scholars
Translational Medicine / 转化医学Complement Drug Development
Martin Kolev
PhD
🏢Apellis Pharmaceuticals🌐USA
Senior Scientist, Complement Therapeutics
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Martin Kolev contributes to the development of complement targeted therapeutics including C3 inhibitors with potential in inflammatory and oncology indications. His work bridges complement biology and translational drug discovery. He collaborates with academic centers on mechanism of action studies.
Share:
🧪Research Fields 研究领域
complement inhibitors
C3
drug discovery
pharmacology
immune disease
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Martin Kolev 的研究动态
Follow Martin Kolev's research updates
留下邮箱，当我们发布与 Martin Kolev（Apellis Pharmaceuticals）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment